Endocrinology (2011) 152:40729
Despite the identification of N-acetyl cysteine, a reactive oxygen species scavenger that is regarded as an effective clinical treatment, therapeutic effectiveness remains limited due to rapid disease progression and diagnosis at a late phase, which leads to the need to explore various therapeutic approaches
The SELECT trial, completed in 2023 with over 17,600 participants, showed a 20% reduction in cardiovascular events in patients with established cardiovascular disease and overweight or obesity without diabetes
GLP-1 receptor agonistsmedications approved for type 2 diabetes and obesityare sometimes used at very low doses in the hope of reducing side effects whilst addressing weight gain and metabolic symptoms common in Hashimoto's thyroiditis
Clinic is manufactured under GMP, HACCP, and ISO 9001:2015 standards, with third-party lab verification for purity, sterility, endotoxin, and heavy metal testing